Work ability following breast cancer – the MyHealth randomized controlled trial
Background and purpose: We previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2025-01-01
|
| Series: | Acta Oncologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actaoncologica/article/view/42221 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841554157098500096 |
|---|---|
| author | Trine A. Horsbøl Lena Saltbæk Caroline Urhammer Randi V. Karlsen Christoffer Johansen Pernille E. Bidstrup Beverley L. Høeg Vibeke Zoffmann Federica Belmonte Ingelise Andersen Anne S. Friberg Mads N. Svendsen Helle G. Christensen Vesna Glavicic Dorte L. Nielsen Susanne O. Dalton |
| author_facet | Trine A. Horsbøl Lena Saltbæk Caroline Urhammer Randi V. Karlsen Christoffer Johansen Pernille E. Bidstrup Beverley L. Høeg Vibeke Zoffmann Federica Belmonte Ingelise Andersen Anne S. Friberg Mads N. Svendsen Helle G. Christensen Vesna Glavicic Dorte L. Nielsen Susanne O. Dalton |
| author_sort | Trine A. Horsbøl |
| collection | DOAJ |
| description | Background and purpose: We previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts self-reported work ability.
Patients/material and methods: A total of 288 patients, potentially active on the labour market, were randomized to MyHealth or control follow-up after primary treatment for early-stage breast cancer (2017–2019). MyHealth included individual self-management sessions, electronic symptom monitoring, and assistance with navigating healthcare services. Control follow-up consisted of biannual outpatient visits with a physician. Linear mixed-effect models were applied to evaluate the effect of MyHealth on self-reported work ability at 6, 12, 24, and 36 months after randomization as measured by the Work Ability Score (WAS).
Results: Work ability increased significantly in both groups during the first 6 months (mean WAS increase MyHealth: 1.64, 95% confidence interval [CI]: 1.26; 2.02 and control: 1.57, 95% CI: 1.17; 1.97) and continued to increase slightly but non-significantly (p-values > 0.13) until end of follow-up at 36 months. Improvement was especially pronounced among patients reporting poor work ability at baseline. Differences in mean WAS between patients in MyHealth and control follow-up were non-significant and close to zero at all time points (–0.21 to 0.48).
Interpretation: The MyHealth follow-up program had no additional effect on self-reported work ability compared to regular follow-up. Future interventions should target patients with poor work ability and include components specifically designed to enhance work ability.
|
| format | Article |
| id | doaj-art-0b82785af4514eab9c356ee3054ca1af |
| institution | Kabale University |
| issn | 1651-226X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Medical Journals Sweden |
| record_format | Article |
| series | Acta Oncologica |
| spelling | doaj-art-0b82785af4514eab9c356ee3054ca1af2025-01-08T17:39:56ZengMedical Journals SwedenActa Oncologica1651-226X2025-01-016410.2340/1651-226X.2025.42221Work ability following breast cancer – the MyHealth randomized controlled trialTrine A. Horsbøl0https://orcid.org/0000-0002-1278-9198Lena Saltbæk1https://orcid.org/0000-0002-2716-9469Caroline Urhammer2Randi V. Karlsen3https://orcid.org/0000-0002-7465-562XChristoffer Johansen4https://orcid.org/0000-0002-4384-206XPernille E. Bidstrup5https://orcid.org/0000-0002-9704-6800Beverley L. Høeg6https://orcid.org/0000-0002-9946-2429Vibeke Zoffmann7https://orcid.org/0000-0003-0571-5331Federica Belmonte8https://orcid.org/0000-0002-2920-5005Ingelise Andersen9https://orcid.org/0000-0002-0076-265XAnne S. Friberg10https://orcid.org/0000-0002-6421-4679Mads N. Svendsen11https://orcid.org/0000-0001-8082-359XHelle G. Christensen12Vesna Glavicic 13Dorte L. Nielsen14https://orcid.org/0000-0002-8766-8729Susanne O. Dalton15https://orcid.org/0000-0002-5485-2730National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark; Cancer Survivorship, Danish Cancer Institute, Copenhagen, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Institute of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, Denmark; Department of Oncology, CASTLE, Copenhagen University Hospital, Copenhagen, Denmark; Psychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Copenhagen, DenmarkPsychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Institute of Psychology, Faculty of Social Sciences, Copenhagen University, Copenhagen, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, DenmarkResearch Unit of Women’s and Children’s Health, the Juliane Marie Center, Copenhagen University Hospital, Copenhagen, DenmarkStatistics and Data Analysis, Danish Cancer Institute, Copenhagen, DenmarkSection of Social Medicine, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, DenmarkDepartment of Clinical Oncology and Palliative Care, Zealand University Hospital, DenmarkDepartment of Clinical Oncology and Palliative Care, Zealand University Hospital, DenmarkDepartment of Clinical Oncology and Palliative Care, Zealand University Hospital, DenmarkInstitute of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, Denmark; Department of Oncology, Herlev and Gentofte University Hospital, Herlev, DenmarkCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark; Institute of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, DenmarkBackground and purpose: We previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts self-reported work ability. Patients/material and methods: A total of 288 patients, potentially active on the labour market, were randomized to MyHealth or control follow-up after primary treatment for early-stage breast cancer (2017–2019). MyHealth included individual self-management sessions, electronic symptom monitoring, and assistance with navigating healthcare services. Control follow-up consisted of biannual outpatient visits with a physician. Linear mixed-effect models were applied to evaluate the effect of MyHealth on self-reported work ability at 6, 12, 24, and 36 months after randomization as measured by the Work Ability Score (WAS). Results: Work ability increased significantly in both groups during the first 6 months (mean WAS increase MyHealth: 1.64, 95% confidence interval [CI]: 1.26; 2.02 and control: 1.57, 95% CI: 1.17; 1.97) and continued to increase slightly but non-significantly (p-values > 0.13) until end of follow-up at 36 months. Improvement was especially pronounced among patients reporting poor work ability at baseline. Differences in mean WAS between patients in MyHealth and control follow-up were non-significant and close to zero at all time points (–0.21 to 0.48). Interpretation: The MyHealth follow-up program had no additional effect on self-reported work ability compared to regular follow-up. Future interventions should target patients with poor work ability and include components specifically designed to enhance work ability. https://medicaljournalssweden.se/actaoncologica/article/view/42221randomized controlled trialwork abilitybreast cancer |
| spellingShingle | Trine A. Horsbøl Lena Saltbæk Caroline Urhammer Randi V. Karlsen Christoffer Johansen Pernille E. Bidstrup Beverley L. Høeg Vibeke Zoffmann Federica Belmonte Ingelise Andersen Anne S. Friberg Mads N. Svendsen Helle G. Christensen Vesna Glavicic Dorte L. Nielsen Susanne O. Dalton Work ability following breast cancer – the MyHealth randomized controlled trial Acta Oncologica randomized controlled trial work ability breast cancer |
| title | Work ability following breast cancer – the MyHealth randomized controlled trial |
| title_full | Work ability following breast cancer – the MyHealth randomized controlled trial |
| title_fullStr | Work ability following breast cancer – the MyHealth randomized controlled trial |
| title_full_unstemmed | Work ability following breast cancer – the MyHealth randomized controlled trial |
| title_short | Work ability following breast cancer – the MyHealth randomized controlled trial |
| title_sort | work ability following breast cancer the myhealth randomized controlled trial |
| topic | randomized controlled trial work ability breast cancer |
| url | https://medicaljournalssweden.se/actaoncologica/article/view/42221 |
| work_keys_str_mv | AT trineahorsbøl workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT lenasaltbæk workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT carolineurhammer workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT randivkarlsen workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT christofferjohansen workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT pernilleebidstrup workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT beverleylhøeg workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT vibekezoffmann workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT federicabelmonte workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT ingeliseandersen workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT annesfriberg workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT madsnsvendsen workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT hellegchristensen workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT vesnaglavicic workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT dortelnielsen workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial AT susanneodalton workabilityfollowingbreastcancerthemyhealthrandomizedcontrolledtrial |